Related Experiment Video
Updated: May 16, 2025

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Published on: January 26, 2018
Novel Nonpeptide as Oxytocin Receptor Agonist
1Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United States.
None:
This highlight describes a series of novel 1,4-benzodiazepine-based nonpeptides as oxytocin receptor (OT) agonists. The reported compounds demonstrate enhanced potency and selectivity compared to reference compounds, warranting further investigation for potential therapeutic applications in the treatment of OT-related pathologies.
More Related Videos
Related Concept Videos
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Opioid Receptors: Overview
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....

